T Cell Engagers for Autoimmune Disease Treatment Infographic
This infographic covers:
- TCE Development & Trials: Gain insights into the latest advancements, from preclinical assets to clinical milestones.
- B Cell Targets: Uncover the leading targets in the field and the rationale behind their selection.
- Investments & Deals: Explore commercial activity over the past decade, with a spotlight on the record-breaking $2.6 billion invested in 2024.
- Clinical Highlights: Learn about early successes, including promising trial results and use cases.
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
